After Loading Buchler
by Ellis Pharmaceutical Consulting, Inc.
510(k) K832789
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK832789 | Date29 Sep 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JAQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.5700
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The After Loading Buchler is a remote-controlled radionuclide system and applicator used in radiology. It is classified as a Class II medical device under regulation number 892.5700 with product code JAQ.
It received FDA 510(k) clearance (K832789) through a traditional submission process on September 29, 1983, and is manufactured by Ellis Pharmaceutical Consulting, Inc. The device is substantially equivalent to a legally marketed predicate device.
Other devices from Ellis Pharmaceutical Consulting, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the After Loading Buchler used for?
The After Loading Buchler is a remote-controlled radionuclide system and applicator used in radiology for delivering radioactive sources to treatment sites, allowing clinicians to administer brachytherapy from a safe distance.
How is the After Loading Buchler supplied and is it reusable?
The device is supplied as a remote-controlled system and applicator designed for repeated use in clinical settings; it is not a single-use item but requires proper maintenance and quality checks between procedures to ensure safe operation.
What regulatory pathway was used for the After Loading Buchler?
The After Loading Buchler received FDA 510(k) clearance through a traditional submission process on September 29, 1983, under K832789, demonstrating substantial equivalence to a legally marketed predicate device.